Method of treating polycystic kidney diseases with ceramide derivatives

Details for Australian Patent Application No. 2012201076 (hide)

Owner Genzyme Corporation

Inventors Natoli, Thomas A.; Ibraghinov-Beskrovnaya, Oxana; Leonard, John P.; Yew, Nelson S.; Cheng, Seng H.

Agent A J Park

Pub. Number AU-A-2012201076

Parent 2008307516

Filing date 24 February 2012

Wipo publication date 22 March 2012

International Classifications

A61K 31/4025 (2006.01) - not condensed and containing further heterocyclic rings, e.g. cromakalim

A61P 13/02 (2006.01) Drugs for disorders of the urinary system

Event Publications

8 March 2012 Complete Application Filed

15 March 2012 Corrigenda

  Complete Applications Filed - Name Index Under the name GENZYME CORPORATION, Application No. 2012201076, under INID (71) correct the applicant name to Genzyme Corporation

22 March 2012 Application Open to Public Inspection

  Published as AU-A-2012201076

31 May 2012 Section 223 Application Allowed

  Genzyme Corporation The time in which to make a further application for a divisional patent has been extended to 17 Mar 2012. Address for service in Australia - A J PARK Level 11 60 Marcus Clarke Street Canberra ACT 2601

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2012201077-Method and system for controlled infusion of therapeutic substances

2012201075-Method and apparatus for a merged power-communication cable in door security environment